참고문헌
- Anglicheau D, Muthukumar T, Suthanthiran M (2010). MicroRNAs: small RNAs with big effects. Transplantation, 90, 105-12.
- Alajez NM, Lenarduzzi M, Ito E, et al (2011). MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Res, 71, 2381-91. https://doi.org/10.1158/0008-5472.CAN-10-2754
- Bartel DP (2009). MicroRNAs: target recognition and regulatory functions. Cell, 136, 215-33. https://doi.org/10.1016/j.cell.2009.01.002
- Chen K, Song F, Calin GA, et al (2008). Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis, 29, 1306-11. https://doi.org/10.1093/carcin/bgn116
- Chen AX, Yu KD, Fan L, et al (2011). Germline genetic variants disturbing the Let-7/LIN28 double-negative feedback loop alter breast cancer susceptibility. PLoS Genet, 7, 1002259. https://doi.org/10.1371/journal.pgen.1002259
- DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88 . https://doi.org/10.1016/0197-2456(86)90046-2
- Davidson MR , Larsen JE , Yang IA , et al (2010). MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma. PLoS One, 5, 12560. https://doi.org/10.1371/journal.pone.0012560
- Esquela-Kerscher A, Slack FJ (2006). Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer, 6, 259-69 https://doi.org/10.1038/nrc1840
- He L, Hannon GJ (2004). MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet, 5, 522-31. https://doi.org/10.1038/nrg1379
- Han Y, Pu R, Han X, et al (2013). Association of a potential functional pre-miR-218 polymorphismand its interaction with hepatitis B virusmutations with hepatocellular carcinoma risk. Liver Int. [Epub ahead of print]
- Higgins JP, Thompson SG (2002). Thompson SG Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58. https://doi.org/10.1002/sim.1186
- Kutanzi KR , Yurchenko OV, Beland FA, et al (2011). MicroRNAmediated drug resistance in breast cancer. Clin Epigenetics, 2, 171-85. https://doi.org/10.1007/s13148-011-0040-8
- Link A, Kupcinskas J, Wex T, et al (2012). Macro-role of microRNA in gastric cancer. Dig Dis, 30, 255-67. https://doi.org/10.1159/000336919
- Liu Z, Wei S, Ma H, et al (2011). A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck. Carcinogenesis, 32, 1668-74. https://doi.org/10.1093/carcin/bgr209
- Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
- Martinez I, Gardiner AS, Board KF, et al (2008). Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene, 27, 2575-82. https://doi.org/10.1038/sj.onc.1210919
- Petrocca F, Visone R, Onelli MR, et al (2008). E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell, 13, 272-86. https://doi.org/10.1016/j.ccr.2008.02.013
- Shi TY, Chen XJ, Zhu ML, et al (2013). A pri-miR-218 variant and risk of cervical carcinoma in Chinese women. BMC Cancer, 13, 19. https://doi.org/10.1186/1471-2407-13-19
- Tran N, O'Brien CJ, Clark J, et al (2010). Potential role of micro-RNAs in head and neck tumorigenesis. Head Neck, 32, 1099-111. https://doi.org/10.1002/hed.21356
- Tie J, Pan Y, Zhao L, et al (2010). MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet, 6, 1000879. https://doi.org/10.1371/journal.pgen.1000879
- Uesugi A, Kozaki K, Tsuruta T, et al (2011). The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer. Cancer Res, 71, 5765-78. https://doi.org/10.1158/0008-5472.CAN-11-0368
- Volinia S, Calin GA, Liu CG, et al (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A, 103, 2257-61. https://doi.org/10.1073/pnas.0510565103
- Wu DW, Cheng YW, Wang J, et al (2010). Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting. Cancer Res, 70, 10392-401. https://doi.org/10.1158/0008-5472.CAN-10-2341
- Wang B, Ma N, Wang YJ (2012). Association Between the hsamir- 27a variant and breast cancer risk: a meta-analysis. Asian Pac J Cancer Prev, 13, 6207-10 https://doi.org/10.7314/APJCP.2012.13.12.6207
- Zhou X, Chen X, Hu L, et al (2010). Polymorphisms involved in the miR-218-LAMB3 pathway and susceptibility of cervical cancer, a case-control study in Chinese women. Gynecol Oncol, 117, 287-90. https://doi.org/10.1016/j.ygyno.2010.01.020
- Zhang LS, Liang WB, Gao LB, et al (2012). Association Between pri-miR-218 Polymorphism and Risk of Hepatocellular Carcinoma in a Han Chinese Population. DNA Cell Biol, 31, 761-65. https://doi.org/10.1089/dna.2011.1326
- Zhang YG, Shi JX, Song CH, et al (2013). Association of mir-499 and mir-149 polymorphisms with cancer risk in the Chinese population: evidence from published studies. Asian Pac J Cancer Prev, 14, 2337-42 https://doi.org/10.7314/APJCP.2013.14.4.2337
피인용 문헌
- rs11134527 A>G and Kawasaki disease susceptibility vol.38, pp.3, 2018, https://doi.org/10.1042/BSR20180367